June 23, 2015 12:44pm
Stem, cell therapy and RegMed equities … notched the falling knife on Tuesday as investors weighed the short term effects of Friday’s quadruple witching hour.
Members only. Please login.
June 23, 2015 12:44pm
Stem, cell therapy and RegMed equities … notched the falling knife on Tuesday as investors weighed the short term effects of Friday’s quadruple witching hour.
Members only. Please login.
35 companies, 1 interpreter!
Insight, foresight and recommendation
5 hours 11 min ago
RegMed Investors (RMi) Closing Bell: starting with sector slippage to a neutral mid-day ending with a negative close
9 hours 28 min ago
RegMed Investors (RMi) - Q1/24 Cell and Gene Therapy Earnings Scorecard Results
11 hours 18 min ago
RegMed Investors (RMi) Research Note: Q1/24 earnings reporting dates, net losses, cash positions, revenue and runway outcomes
14 hours 7 min ago
RegMed Investors’ (RMi) pre-open: quiet weeks of economic data and sector earnings will flip the sentiment switch
My motto … never leave an investor uninformed! I say today what others won’t, so you can do what others can’t.
My name is Henry McCusker; I endorse these opinions under my own name and with a subscription based membership.
Do you have an opinion you would like to share with us? We would like to hear from you.
Please e-mail us at hwm@regmedinvestors.com.
Editor and Publisher ... Henry McCusker enters his tenth (10th) year at RegMed Investors